At the HSG Healthspan Lab we focus on research to extend the “Healthy Lifespan”

AlpinaSana’s fully automated scanner analyzes each meal’s nutritional content in under a second, eliminating the need for manual food logs. With a measurement accuracy of 80–90%—compared to under 30% in typical self-reporting—the tracker supports better clinical decisions and patient outcomes. Additionally, it helps reduce up to 60% of food waste through targeted meal adjustments and eases kitchen staff workload while cutting costs. The system’s integration with hospital information platforms streamlines workflows, and all data are processed in compliance with applicable data protection regulations, ensuring both reliability and confidentiality.

4xSleep is an interdisciplinary research team developing an adjustable mattress with active firmness and temperature control for anyone willing to improve their sleep. The mattress bridges the gap between sleep research and available solutions on the market, optimising spinal alignment, alleviating pain, reducing sleep onset latency, and enhancing overall sleep quality.

Entrepreneurship typically has been linked to tremendous number of working hours, hugely demanding responsibilities for organizing business structure/environment, decision-making under a high-level of ambiguity and uncertainty that results in a feeling of stress and ultimately leads to problems in sleep and health, as well as a decrease in work performance. The general aim of the current project is to particularly investigate the contribution of sleep status on decision-making and entrepreneurial performance and test whether different interventions can improve decisions and health of entrepreneurs.

Non-communicable diseases (NCDs), including common mental disorders, not only impose an enormous health burden on individuals but also lead to substantial economic burdens for healthcare systems. Especially individuals with lower socioeconomic status are affected by NCDs. Digital therapeutics (DTx) have the potential to offer low-cost personalized interventions easing the burden of NCDs and addressing inequalities in health. This project investigates the importance of preventive care and offers a roadmap toward DTx for healthy longevity with a focus on the region of Eastern Switzerland.

Our research team at the Singapore-ETH Centre is dedicated to addressing the rising prevalence of non-communicable diseases (NCDs) and common mental disorders (CMDs) in Southeast Asia, particularly in Singapore. To combat this challenge, we are developing and evaluating a scalable digital health intervention called LvL UP.

Investing is often associated with long hours, high-pressure decisions, and the need to process complex financial data under uncertainty. While investors rely on analytical skills and experience, physiological factors such as sleep quality, stress responses, and blood glucose level may play a crucial yet overlooked role in shaping their decision-making processes. Disruptions in these areas can impact cognitive function, emotional regulation, and risk assessment, potentially leading to suboptimal investment choices. Our study aims to investigate the relationship between sleep patterns, stress physiology, and blood glucose fluctations influencing investment performance. By utilizing sleep trackers, continuous glucose monitoring, and cortisol sampling, we will assess how fluctuations in these physiological factors affect cognitive performance and risk-taking behavior. Our research will provide valuable insights that can help investors optimize their decision-making processes, ultimately leading to better financial outcomes and enhanced resilience in high-pressure environments.